» Articles » PMID: 30636631

Trends in Descriptions of Palliative Care in the Cancer Clinical Practice Guidelines Before and After Enactment of the Cancer Control Act (2007): Content Analysis

Overview
Publisher Biomed Central
Specialty Critical Care
Date 2019 Jan 15
PMID 30636631
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Palliative care was a priority issue in the Cancer Control Act enacted in 2007 in Japan, and this has resulted in efforts being made toward educational goals in clinical settings. An investigation of how descriptions of palliative care for the treatment of cancer have changed in clinical practice guidelines (CPGs) could be expected to provide a better understanding of palliative care-related decision-making. This study aimed to identify trends in descriptions of palliative care in cancer CPGs in Japan before and after enactment of the Cancer Control Act.

Methods: Content analysis was used to count the lines in all relevant CPGs. We then compared the number of lines and the proportion of descriptions mentioning palliative care at two time points: the first survey (selection period: February to June 2007) and the second survey (selection period: February to December 2015). Descriptions from the CPGs were independently selected from the Toho University Medical Media Center and Medical Information Network Distribution Service databases, and subsequently reviewed, by two investigators.

Results: Descriptions were analyzed for 10 types of cancer. The proportion of descriptions in the first survey (4.4%; 933/21,344 lines) was similar to that in the second survey (4.5%; 1325/29,269 lines).

Conclusions: After the enactment of the Cancer Control Act, an increase was observed in the number, but not in the proportion, of palliative care descriptions in Japanese cancer CPGs. In the future, CPGs can be expected to play a major role in helping cancer patients to incorporate palliative care more smoothly.

Citing Articles

Encouraging outpatients in an acute hospital for the relief of cancer-related pain: a qualitative study.

Hinata M, Miyazaki K, Nakayama T, Tokunaga M, Watanabe T, Nawata S BMC Palliat Care. 2023; 22(1):109.

PMID: 37528395 PMC: 10391770. DOI: 10.1186/s12904-023-01236-y.


Advance Care Planning and Goals of Care Discussion: Barriers from the Perspective of Medical Residents.

Dias L, Frutig M, Bezerra M, Barra W, Castro L, Rego F Int J Environ Res Public Health. 2023; 20(4).

PMID: 36833934 PMC: 9961136. DOI: 10.3390/ijerph20043239.


Advance care planning and goals of care discussion: the perspectives of Brazilian oncologists.

Dias L, Bezerra M, Barra W, Carvalho A, Castro L, Rego F BMC Palliat Care. 2022; 21(1):165.

PMID: 36138380 PMC: 9502602. DOI: 10.1186/s12904-022-01052-w.

References
1.
Washington K, Parker Oliver D, Gage L, Albright D, Demiris G . A multimethod analysis of shared decision-making in hospice interdisciplinary team meetings including family caregivers. Palliat Med. 2015; 30(3):270-8. PMC: 4753099. DOI: 10.1177/0269216315601545. View

2.
Caraceni A, Hanks G, Kaasa S, Bennett M, Brunelli C, Cherny N . Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012; 13(2):e58-68. DOI: 10.1016/S1470-2045(12)70040-2. View

3.
Mast K, Salama M, Silverman G, Arnold R . End-of-life content in treatment guidelines for life-limiting diseases. J Palliat Med. 2005; 7(6):754-73. DOI: 10.1089/jpm.2004.7.754. View

4.
Piggott M, McGee H, Feuer D . Has CONSORT improved the reporting of randomized controlled trials in the palliative care literature? A systematic review. Palliat Med. 2004; 18(1):32-8. DOI: 10.1191/0269216304pm857oa. View

5.
Fowell A, Johnstone R, Finlay I, Russell D, Russell I . Design of trials with dying patients: a feasibility study of cluster randomisation versus randomised consent. Palliat Med. 2006; 20(8):799-804. DOI: 10.1177/0269216306072554. View